Home/ Supplements/ Phosphorus/ Syntha-6 Vanilla Ice Cream

Syntha-6 Vanilla Ice Cream

product on market Powder BSN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 11% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product provides protein and carbohydrates, which are supported by strong evidence for muscle recovery and energy maintenance. These macronutrients are fundamental to dietary health and athletic performance. The evidence coverage for this specific ingredient profile is limited, though the components are generally recognized as safe.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Syntha-6 Vanilla Ice Cream
Open Full PDF View on NIH DSLD →
Details

Label Data

44 Gram(s)
Serving Size
1
Servings
Mineral
Product Type
11%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
200 {Calories}
Total Fat
6 g (9% DV)
Cholesterol
60 mg (20% DV)
Total Carbohydrates
13 g (4% DV)
Protein
23 g (46% DV)
Calcium
100 mg (10% DV)
100 mg (10% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
Sodium
190 mg (8% DV)
Potassium
190 mg (5% DV)

Other Ingredients

a sustained release ultra-premium Protein matrix richmix Sunflower powder Litesse(R) II Polydextrose Natural & Artificial flavors Nutrisperse MCT powder Ticalose(R) Cellulose Gum Sucralose Acesulfame Potassium Lecithin Aminogen Papain
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

RECOMMENDED USE: As a dietary supplement, take 1 packet (equaling approx. 23 grams of protein) with 4-5 oz. of cold water or any beverage of your choice. Use approximately 4-5 oz. of liquid per 1 packet of powder. Vary the amount of liquid to achieve your desired flavor and consistency. Drink 2-4 servings daily, or as needed to satisfy your protein or body shaping requirements. To increase your protein intake per serving and to achieve and amazing milk shake taste, use non-fat or low fat milk.

Warnings & Precautions

Allergen Warning: Manufactured on equipment which processes products containing milk, egg, soybeans, shellfish, fish oil, tree nuts, and peanut flavor.

Formulation Notes

DESIGNED FOR: Any individual who wants an ultra-premium protein powder to help them reach their nutritional and physique goals.

ASPARTAME FREE

Additional Information

AN ULTRA-PREMIUM SUSTAINED RELEASE PROTEIN POWDER

CORE SERIES

FINISH FIRST.

NET WT.

NUTRITION* -LEAN MUSCLE* -DEFINITION* -WEIGHT MANAGEMENT*

V.1.611.0206US

Metadata

Product Details

UPC / SKU8 34266 00611 3
DSLD Entry Date2011-11-25
Product TypeMineral
FormPowder
BrandBSN
DSLD ID2325
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.